Strong margins mask volume decline; growth execution at risk

MD stated ₹930/kg Q1 FY27 vs ₹812/kg Q1 FY26 = 14.5% growth, corroborated

2,624 MT Q1 FY27 vs 3,015 MT Q1 FY26 = 13% decline, claim contradicted

Delivered data shows OPM 11.8% (closest proxy); EBITDA 12.7% per transcript, supported by flat revenue + 138% PAT growth

MD stated US sales increased 13% YoY; 121% QoQ correlated with EU delays spilling to Q2, internally consistent

MD hedged with 'stable but subject to freight, labor, farm-gate pressures'; doubled freight costs Q4→Q1 not offset in margin guidance

Prior: 14,000 MT guidance (start of FY26). Now: 12,000 MT for FY27 per MD. Next round 14,000-15,000 MT by FY28-29, delayed by 1 year.

Prior: 50% by FY27. Now: 35-40% throughout FY27. Current Q1: 38%. Execution gap blamed on labor, logistics.

RTE contribution 16% Q1 (was 15% prior year), targeting 18-20% by year-end. Realization improved $11.2→$12.05/kg.

Prior guide: 7% EBITDA sustain, upside to 10%. Delivered: 12.7% in Q1. BUT hedged with cost/freight/farm-gate pressures going forward.

Margins stable due to volume growth offsetting cost rises, stable export realizations in USD, and rupee depreciation benefits. Freight costs doubled Q4→Q1 from war; uncertain duration. Farm-gate prices rising but pass-through via higher realization expected.

Labor shortage in Apr-May was temporary; Q2 recovery expected. EU shipments delayed, spilled to Q2. Order book strong through mid-Q3. 12,000 MT remains doable for FY27.

38% similar to prior year. New internal plans to maintain 35-40% through FY27. Next phase 14,000-15,000 MT targeted for FY28-29. FTAs will support but full benefit takes 1 year post-implementation.

RTE 16% of volume in Q1, targeting 18-20% FY27. Margin uplift ~$0.50/kg USD vs RTC. New products and inquiries supporting growth. Realization up $11.2→$12.05/kg.

No refunds received yet as of Q1. Tariffs compensated by customers. Uncertain timing for refunds (govt court battles ongoing). No clarity on when/if refunds will arrive.

FTAs typically take 1 year minimum to fully implement. UK effective July, minor issues remain. EU FTA hoped by Dec 2026 or Jan 2027. Full benefit expected Q1 FY28+. Non-tariff barriers (e.g., 50% testing of Indian shrimp) remain impediment.

Russia: Not yet in Q1, likely Q2/Q3. Australia: In discussion stage, customer audits pending. Japan: NEW—business initiated, will reflect Q2+ (first time >decade).

Order book good through mid-Q3 currently. Subject to shipment delays and supply-chain disruptions. Order book position keeps shifting due to logistics issues.

ADD final determination Sep 2026 (currently 3.4% vs 1.35% prior). CVD review Dec 2026; expecting reduction to 5.77% if India's RoDTEP/duty-drawback explanations accepted. If reduction granted, will also get refund on prior payments.

Proprietary customer products in both RTE and RTC being produced and shipped. ~3-4% of total sales expected FY27 for specific new product; could scale to 500 MT annually. Cannot disclose details due to customer confidentiality.

Start-of-year/Q4 guidance restated. Q1 delivered 2,624 MT (~22% of target). Q2+ must recover 9,376 MT to achieve.

Q1 delivered 8.4% PAT margin, exceeding prior 7-10% EBITDA guidance. MD hedging on freight (doubled) and farm-gate price rises offsetting realization gains.

RTE facility utilization targeted 35-40%; capacity expansion not mentioned; focus on utilization optimization vs new spend

Prior multi-year guidance (₹1,200+ Cr growth) appears abandoned. Q1 flat revenue, 13% volume decline. FY27 target 12,000 MT vs 14,000 MT start-of-year implies missed opportunity in early year. Q2+ recovery uncertain given logistics/tariff headwinds.

Ocean freight costs more than doubled since Q4 FY26 due to war disruptions. MD stated this is a major headwind to margin stability. Reversal timing highly uncertain; any prolonged geopolitical disruption further pressures profitability.

Prior tariff refunds (from 50% periods) not yet received. CVD reduction expected Dec 2026 is contingent on US govt acceptance of India's RoDTEP/duty-drawback explanation. No clarity on magnitude or timing of potential CVD relief (hoped 5.77% reduction from current level).

UK FTA effective July 2026 but non-tariff barriers (e.g., 50% shipment testing still required) persist. EU FTA not yet implemented; hoped by end-2026 or early 2027. Full benefit to margins/volume expected only Q1 FY28+. Delay extends execution risk.

Farm-gate prices rising (6-7% jump noted in Q1→Q2 so far). While MD states this is healthy for farmer economics, it signals tightening raw material costs. Pass-through to export realizations not guaranteed if customer mix shifts to price-sensitive segments.